Long-term outlook for transcatheter aortic valve replacement

Andras P Durko; Ruben L Osnabrugge; A Pieter Kappetein

doi:10.1016/j.tcm.2017.08.004

Long-term outlook for transcatheter aortic valve replacement

Trends Cardiovasc Med. 2018 Apr;28(3):174-183. doi: 10.1016/j.tcm.2017.08.004. Epub 2017 Aug 10.

Authors

Andras P Durko¹, Ruben L Osnabrugge², A Pieter Kappetein²

Affiliations

¹ Department of Cardio-Thoracic Surgery, Erasmus University Medical Center Rotterdam, Thoraxcentrum, s'-Gravendijkwal 230, 3015CE, Rotterdam, The Netherlands. Electronic address: a.durko@erasmusmc.nl.
² Department of Cardio-Thoracic Surgery, Erasmus University Medical Center Rotterdam, Thoraxcentrum, s'-Gravendijkwal 230, 3015CE, Rotterdam, The Netherlands.

PMID: 28838702
DOI: 10.1016/j.tcm.2017.08.004

Abstract

Transcatheter aortic valve replacement (TAVR) revolutionized the treatment of severe symptomatic aortic stenosis (AS). TAVR is increasingly offered for lower-risk patients. The role and place of TAVR in the future treatment of AS is not clear yet. In this review, we discuss the long-term outlook for TAVR, its challenges and its relationship to conventional surgical aortic valve replacement.

Keywords: Complications; Durability; Future outlook; TAVI; TAVR, transcatheter aortic valve implantation; Transcatheter aortic valve replacement.

Publication types

Review

MeSH terms

Aortic Valve Stenosis / diagnostic imaging
Aortic Valve Stenosis / physiopathology
Aortic Valve Stenosis / surgery*
Clinical Decision-Making
Diffusion of Innovation
Forecasting
Humans
Patient Selection
Risk Factors
Severity of Illness Index
Time Factors
Transcatheter Aortic Valve Replacement / adverse effects
Transcatheter Aortic Valve Replacement / trends*
Treatment Outcome